- Garcia H, Gonzalez A, Gilman R. Taenia solium cysticercosis and its impact in neurological disease. Clin Microbiol Rev. 2020;33(3):15–19. doi:10.1128/CMR.00085-19.
- Nash T, Ware J, Mahanty S. Intraventricular neurocysticercosis: experience and long-term outcome from a tertiary referral center in the United States. Am J Trop Med Hyg. 2018;98(6):1755–1762. doi:10.4269/ajtmh.18-0085.6.
- Coyle C. Neurocysticerosis: an individualized approach. Infect Dis Clin North Am. 2019;33(1):153–168. doi:10.1016/j.idc.2018.10.007.7.
- Serpa J, Graviss E, Kass J, White A. Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore). 2011;90(1):81–86. doi:10.1097/md.0b013e318206d13e. 8.
- Torres-Corzo J, Vecchia R, Rangel-Castilla L. Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy. J Neurosurg. 2006;104(5):746–748. doi:10.3171/jns.2006.104.5.746.
- White A, Coyle C, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018;66(8):1159–1163. doi:10.1093/cid/ciy157.
- Rajshekhar V, Raghava M, Prabhakaran V, Oommen A, Muliyil J. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology. 2006;67(12):2135–2139. doi:10.1212/01.wnl.0000249113.11824.64.
- Moyano L, Saito M, Montano S, et al; Cysticercosis Working Group in Peru. Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. PLoS Negl Trop Dis. 2014;8(2):e2692. doi:10.1371/journal.pntd.0002692.
- Hamamoto F, Zanini M, Fleury A. Hydrocephalus in neurocysticercosis: challenges for clinical practice and basic research perspectives. World Neurosurg. 2019;126:264–271. doi:10.1016/j.wneu.2019.03.071.
- Kumar Chakrabartty D, Jyoti Pegu B, Kumar Singh A. Role of advanced magnetic resonance imaging techniques in the evaluation of intracranial masses and mass like lesions. JMSCR. 2021;9(4):143–162 doi:10.18535/jmscr/v9i4.23.
- Teegala R, Rajesh K, Raviprasad V, Chennappa Y. Emergency neuroendoscopic management of third ventricular neurocysticercosis cyst presented with Bruns syndrome: report of two cases and review of literature. J Korean Neurosurg Soc. 2014;55(3):173–177. doi:10.3340/jkns.2014.55.3.173.
- Garcia H, Gonzales I, Lescano A, et al; Cysticercosis Working Group in Peru. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014;14(8):687–695. doi:10.1016/S1473-3099(14)70779-0.
- Garcia H, Pretell E, Gilman R, et al; Cysticercosis Working Group in Peru. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249–258. doi:10.1056/nejmoa031294.
- Walton D, Castell H, Collie C, et al. Antiepileptic drugs for seizure control in people with neurocysticercosis. Cochrane Database Syst Rev. 2021;11(11):CD009027. doi:10.1002/14651858.CD009027.pub4.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 5
Case Studies
Intraventricular neurocysticercosis causing obstructing hydrocephalus
Alejandro Pereza Department of Internal Medicine, Baylor University Medical Center, Dallas, TexasCorrespondence[email protected]
https://orcid.org/0000-0002-5894-4026
, MDhttps://orcid.org/0000-0002-5894-4026, Gaurav Syngalb Department of Radiology, Baylor University Medical Center, Dallas, Texashttps://orcid.org/0000-0003-4127-3075
, MDhttps://orcid.org/0000-0003-4127-3075, , MD, , MD & , MD